Serum endocan levels as a marker of disease activity in patients with Behçet disease

Journal of the American Academy of Dermatology

Volumn 70, Issue 2, 2014, Pages 291-296

  Balta, Ilknur ^a   Balta, Sevket ^b   Koryurek, Ozgul Mustu ^c   Demirkol, Sait ^b   Mikhailidis, Dimitri P ^d   Celik, Turgay ^b   Cakar, Mustafa ^b   Kucuk, Ugur ^b   Eksioglu, Meral ^c   Kurt, Yasemin Gulcan ^b  

^a Kecioren Training and Research Hospital ^*  (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

^c ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Beh et disease; endocan; endothelium; inflammation; intercellular adhesion molecule; leukocyte function associated antigen

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; ENDOCAN; PROTEOGLYCAN; UNCLASSIFIED DRUG; ESM1 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; ARTICLE; BEHCET DISEASE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SEVERITY OF ILLNESS INDEX;

ADULT; BEHCET SYNDROME; BIOMARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROTEOGLYCANS; REFERENCE VALUES; ROC CURVE; SEVERITY OF ILLNESS INDEX;

EID: 84892671705     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2013.09.013     Document Type: Article

References (25)

1. H. Behcet Uber Residivierende, Aphtose Durch Ein Virus Verursachte Geschwure Am Mund, Am Auge Und an Den Genitalien Derm Wschr 105 1937 1152 1157
2. T. Sakane, M. Takeno, N. Suzuki, and G. Inaba Behçet's disease N Engl J Med 341 1999 1284 1291
3. M. Cekmen, C. Evereklioglu, H. Er, H.S. Inalöz, S. Doganay, Y. Türköz, and I.H. Ozerol Vascular endothelial growth factor levels are increased and associated with disease activity in patients with Behçet's syndrome Int J Dermatol 42 2003 870 875
4. Ekiz O, Balta I, Sen BB, Rifaiogl EN, Ergin C, Balta S, Demirkol S. Mean platelet volume in recurrent aphthous stomatitis and Behcet disease. Angiology doi:10.1177/0003319713492375. Published online June 13, 2013.
5. M.A. Oztürk, S. Unverdi, S.O. Oktar, N. Bukan, O. Gülbahar, and K. Ureten et al. Vascular endothelial growth factor and carotid intima-media thickness in patients with Behçet's disease Clin Rheumatol 27 2008 961 966
6. E. Haznedaroglu, Y. Karaaslan, Y. Büyükaşik, A. Koşar, O. Ozcebe, and B.C. Haznedaroglu et al. Selectin adhesion molecules in Behçet's disease Ann Rheum Dis 59 2000 61 63
7. P. Lassalle, S. Molet, A. Janin, J.V. Heyden, J. Tavernier, and W. Fiers et al. ESM-1 is a novel human endothelial cell-specific molecule expressed in lung and regulated by cytokines J Biol Chem 271 1996 20458 20464
8. S. Sarrazin, E. Adam, M. Lyon, F. Depontieu, V. Motte, and C. Landolfi et al. Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy Biochim Biophys Acta 1765 2006 25 37
9. D. Béchard, A. Scherpereel, H. Hammad, T. Gentina, A. Tsicopoulos, and M. Aumercier et al. Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1 J Immunol 167 2001 3099 3106
10. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease Lancet 335 1990 1078 1080
11. M.T. Inanc, N. Kalay, T. Heyit, I. Ozdogru, M.G. Kaya, and A. Dogan et al. Effects of atorvastatin and lisinopril on endothelial dysfunction in patients with Behçet's disease Echocardiography 27 2010 997 1003
12. M. Suzuki Kurokawa, and N. Suzuki Behcet's disease Clin Exp Med 4 2004 10 20
13. S.M. Zhang, L. Zuo, Q. Zhou, S.Y. Gui, R. Shi, and Q. Wu et al. Expression and distribution of endocan in human tissues Biotech Histochem 87 2012 172 178
14. J.W. Shin, R. Huggenberger, and M. Detmar Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesis Blood 112 2008 2318 2326
15. M. Delehedde, L. Devenyns, C.-A. Maurage, and R.R. Vivès Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan Int J Cell Biol 2013 2013 705027
16. A. Scherpereel, F. Depontieu, B. Grigoriu, B. Cavestri, A. Tsicopoulos, and T. Gentina et al. Endocan, a new endothelial marker in human sepsis Crit Care Med 34 2006 532 537
17. D. Béchard, T. Gentina, M. Delehedde, A. Scherpereel, M. Lyon, and M. Aumercier et al. Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity J Biol Chem 276 2001 48341 48349
18. D. Bechard, V. Meignin, A. Scherpereel, S. Oudin, G. Kervoaze, and P. Bertheau et al. Characterization of the secreted form of endothelial-cell- specific molecule 1 by specific monoclonal antibodies J Vasc Res 37 2000 417 425
19. M. Caliskan, S. Yilmaz, E. Yildirim, H. Gullu, D. Erdogan, and O. Ciftci et al. Endothelial functions are more severely impaired during active disease period in patients with Behcet's disease Clin Rheumatol 26 2007 1074 1078
20. Balta I, Balta S, Demirkol S, Mikhailidis DP, Celik T, Akhan M, et al. Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease. Br J Dermatol doi:10.1111/bjd.12525. Published online July 25, 2013.
21. A. Grützkau, S. Krüger-Krasagakes, H. Baumeister, C. Schwarz, H. Kögel, and P. Welker et al. Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206 Mol Biol Cell 9 1998 875 884
22. M. Harada, K. Mitsuyama, H. Yoshida, S. Sakisaka, E. Taniguchi, and T. Kawaguchi et al. Vascular endothelial growth factor in patients with rheumatoid arthritis Scand J Rheumatol 27 1998 377 380
23. M. Terai, K. Yasukawa, S. Narumoto, S. Tateno, S. Oana, and Y. Kohno Vascular endothelial growth factor in acute Kawasaki disease Am J Cardiol 83 1999 337 339
24. E. Rennel, S. Mellberg, A. Dimberg, L. Petersson, J. Botling, and A. Ameur et al. Endocan is a VEGF-A and PI3K regulated gene with increased expression in human renal cancer Exp Cell Res 313 2007 1285 1294
25. M.R. Abid, X. Yi, K. Yano, S.-C. Shih, and W.C. Aird Vascular endocan is preferentially expressed in tumor endothelium Microvasc Res 72 2006 136 145